Does CETUXIMAB Cause Interstitial lung disease? 274 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 274 reports of Interstitial lung disease have been filed in association with CETUXIMAB (ERBITUX). This represents 1.9% of all adverse event reports for CETUXIMAB.
274
Reports of Interstitial lung disease with CETUXIMAB
1.9%
of all CETUXIMAB reports
126
Deaths
177
Hospitalizations
How Dangerous Is Interstitial lung disease From CETUXIMAB?
Of the 274 reports, 126 (46.0%) resulted in death, 177 (64.6%) required hospitalization, and 56 (20.4%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CETUXIMAB. However, 274 reports have been filed with the FAERS database.
What Other Side Effects Does CETUXIMAB Cause?
Off label use (1,549)
Rash (883)
Diarrhoea (874)
Neutropenia (744)
Nausea (663)
Malignant neoplasm progression (662)
Dyspnoea (542)
Decreased appetite (541)
Vomiting (533)
Death (518)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which CETUXIMAB Alternatives Have Lower Interstitial lung disease Risk?
CETUXIMAB vs CETYLPYRIDINIUM
CETUXIMAB vs CEVIMELINE
CETUXIMAB vs CHAMPIX
CETUXIMAB vs CHANTIX
CETUXIMAB vs CHENODIOL